Brief intensive therapy for older adults with newly diagnosed Burkitt or atypical Burkitt lymphoma/leukemia

Older patients with Burkitt lymphoma/leukemia (BL) have inferior outcomes. Because cyclophosphamide is highly active in BL and can be dose-escalated without stem-cell rescue, we designed a short, cyclophosphamide-intensive regimen without anthracyclines for patients aged ≥30 with untreated, non-HIV-...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Leuk Lymphoma
Autori principali: Kasamon, Yvette L., Brodsky, Robert A., Borowitz, Michael J., Ambinder, Richard F., Crilley, Pamela A., Cho, Steve Y., Tsai, Hua-ling, Smith, B. Douglas, Gladstone, Douglas E., Carraway, Hetty E., Huff, Carol Ann, Matsui, William H., Bolaños-Meade, Javier, Jones, Richard J., Swinnen, Lode J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2012
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4234101/
https://ncbi.nlm.nih.gov/pubmed/22835045
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2012.715346
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi